Breast Cancer Research Stamp Reauthorization Act of 2026

119th Congress Introduced by Don Bacon and 11 co-sponsors

Extends USPS authority to issue a breast cancer research semipostal stamp through 2037, preserving a voluntary funding stream for research.

Introduced in House

Overview

Bill: HR 8358

Session: 119th Congress

Title: Breast Cancer Research Stamp Reauthorization Act of 2026

Purpose: To extend the authority of the United States Postal Service (USPS) to issue a semipostal stamp that raises funds for breast cancer research.

Introduced: April 16, 2026

Primary sponsor: Representative Van Duyne, with a bipartisan group of co-sponsors

Key Provisions

Section 2 extends the authorization for USPS to issue a semipostal stamp dedicated to raising funds for breast cancer research.

Specifically, the bill amends Section 414(h) of title 39, United States Code, by replacing the expiration year “2027” with “2037.”

Effectively, the authority for USPS to issue the breast cancer semipostal stamp is extended by ten years.

What It Would Change

The USPS would retain the ability to issue a semipostal (a fundraising postage stamp) whose surcharge funds breast cancer research.

The reauthorization extends the period during which such stamps may be issued, enabling continued voluntary contributions from stamp purchasers to breast cancer research funding.

Who Is Affected

Stakeholders include:

United States Postal Service and its operations regarding semipostal stamps
Breast cancer research programs that receive funds from semipostal stamp surcharges
Stamp purchasers who opt to buy the semipostal stamps (and thus contribute to research funding)
Public health and cancer research funding communities that rely on these funds

Procedural and Timeline Aspects

The bill has been introduced and referred to multiple committees (Oversight and Government Reform; Energy and Commerce; Armed Services) for consideration.

The core procedural change is a straightforward statutory extension; no new funding mechanism or dollar amounts are specified within the bill text.

If enacted, the extension would take effect prospectively, continuing the semipostal program through 2037, assuming ongoing authorization and any implementing regulations align with existing semipostal stamp programs.

Potential Impact

Financial: Provides continued, predictable funding support for breast cancer research through voluntary stamp purchases.

Strategic: Maintains a public-facing fundraising mechanism that engages the public in supporting research.

Administrative: Requires USPS to continue administering the semipostal program under its existing framework, with the extended expiration date guiding future issuance decisions.

Summary

HR 8358 seeks a decade-long extension (through 2037) of USPS authority to issue a semipostal stamp dedicated to breast cancer research funding. The measure preserves a voluntary funding stream for research and involves standard congressional procedures for authorization, with sponsorship from a bipartisan group of members.